Bioceltix S.A. (WSE:BCX)
88.60
+1.80 (2.07%)
Apr 28, 2026, 5:00 PM CET
Bioceltix Employees
Bioceltix had 36 employees as of December 31, 2024. The number of employees increased by 8 or 28.57% compared to the previous year.
Employees
36
Change (1Y)
8
Growth (1Y)
28.57%
Revenue / Employee
n/a
Profits / Employee
-360.69K PLN
Market Cap
427.44M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36 | 8 | 28.57% |
| Dec 31, 2023 | 28 | 8 | 40.00% |
| Dec 31, 2022 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BIOTON | 364 |
| Captor Therapeutics Spolka Akcyjna | 91 |
| Ryvu Therapeutics | 228 |
| Synthaverse | 239 |
| Mabion | 213 |
| Molecure | 71 |
| Poltreg | 33 |
| Urteste | 36 |
Bioceltix News
- 3 months ago - Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions - Business Wire
- 7 months ago - 5 High Yield CEFs With Steep Discounts Right Now - Forbes
- 8 months ago - Certain BlackRock Sector Equity Closed-End Funds Announce Updates to Investment Objectives and Principal Investment Strategies - Business Wire
- 1 year ago - Certain BlackRock Funds Announce Final Results of Tender Offers - Business Wire
- 1 year ago - Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers - Business Wire
- 1 year ago - BlackRock Announces Distribution Increases for Certain Closed-End Funds - Business Wire
- 1 year ago - These 15 Dividends Could Be Great In 2025 - Forbes
- 3 years ago - CORRECTING and REPLACING BlackRock Closed-End Fund Share Repurchase Program Update - Business Wire